CXCL8 and pulmonary arterial hypertension: The IC50 for JQ1+ suppression of TNFα-induced CXCL8 release was 3 times higher than that required for TNFα-stimulated IL-6 release in both control (308 ± 70 nM) and PAH cells (313 ± 24 nM).